OBJECTIVE -To investigate whether hyperglycemia is associated with increased cancer risk.
RESEARCH DESIGN AND METHODS -In the VästerbottenIntervention Project of northern Sweden, fasting and postload plasma glucose concentrations were available for 33,293 women and 31,304 men and 2,478 incident cases of cancer were identified. Relative risk (RR) of cancer for levels of fasting and postload glucose was calculated with the use of Poisson models, with adjustment for age, year of recruitment, fasting time, and smoking status. Repeated measurements 10 years after baseline in almost 10,000 subjects were used to correct RRs for random error in glucose measurements.RESULTS -Total cancer risk in women increased with rising plasma levels of fasting and postload glucose, up to an RR for the top versus bottom quartile of 1.26 (95% CI 1.09 -1.47) (P trend Ͻ0.001) and 1.31 (1.12-1.52) (P trend ϭ 0.001), respectively. Correction for random error in glucose measurements increased these risks up to 1.75 (1.32-2.36) and 1.63 (1.26 -2.18), respectively. For men, corresponding uncorrected RR was 1.08 (0.92-1.27) (P trend ϭ 0.25) and 0.98 (0.83-1.16) (P trend ϭ 0.99), respectively. Risk of cancer of the pancreas, endometrium, urinary tract, and of malignant melanoma was statistically significantly associated with high fasting glucose with RRs of 2.49 (1.23-5.45) (P trend ϭ 0.006), 1.86 (1.09 -3.31) (P trend ϭ 0.02), 1.69 (0.95-3.16) (P trend ϭ 0.049), and 2.16 (1.14 -4.35) (P trend ϭ 0.01), respectively. Adjustment for BMI had no material effect on risk estimates.CONCLUSIONS -The association of hyperglycemia with total cancer risk in women and in women and men combined for several cancer sites, independently of obesity, provides further evidence for an association between abnormal glucose metabolism and cancer.
Diabetes Care 30:561-567, 2007T ype 2 diabetes, an extreme state of glucose intolerance, is associated with elevated plasma levels of glucose and insulin, both before and after its diagnosis, and is associated with an increased risk of cancers of the liver, pancreas, colon, endometrium, kidney, and breast (1,2). Less is known, however, about the effect on cancer risk of moderately elevated glucose levels among nondiabetic subjects.Recently, total cancer risk was reported to be modestly increased in women and men with elevated levels of fasting glucose in a very large cohort study of 1.3 million Korean men and women with 53,833 incident cases of cancer (3). Five substantially smaller prospective studies (4 -8) with a total number of ϳ11,000 incident cases of cancer also have reported data on associations between fasting or postload glucose and cancer incidence or mortality. Here, we report the results from a prospective study in northern Sweden, with the aim to estimate the relationship of hyperglycemia, as measured by fasting and postload glucose, with the risk of cancer overall and the risk of cancer at specific organ sites.
RESEARCH DESIGN AND METHODS
The Northern Sweden Health and Disease CohortThe Västerbotten Interventio...